Latest scientific findings give hope for people with incurable retinal degeneration
Humans rely dominantly on their eyesight. Losing vision means not being able to read, recognize faces or find objects. Macular degeneration is one of the major reasons for visual impairment, round the globe, close to 200 million people are affected. Photoreceptors in the retina are responsible to capture the light coming from the environment through the eye. Diseased photoreceptors lose their sensitivity to light, which can lead to impaired vision or even complete blindness. Scientists of the Institute of Molecular and Clinical Ophthalmology Basel (IOB) together with colleagues from the German Primate Center (DPZ) – Leibniz Institute for Primate Research in Göttingen have developed a completely new therapeutic approach based on gene therapy. They managed to activate degenerated photoreceptors using near-infrared light (Science).
The main cause of blindness in industrialized countries is the degeneration of photoreceptors, including age-related macular degeneration and retinitis pigmentosa. During the progression of degenerative photoreceptor diseases, light-sensitive and light-insensitive photoreceptor regions in the retina coexist. For example, macular degeneration patients lose vision in the central portion of their retina but retain peripheral eyesight.
Scientists have now succeeded in developing a new therapeutic approach to restore light sensitivity in degenerating retina without negatively affecting remaining vision. They were inspired by species found in nature, such as bats and snakes, that can localize near-infrared light emitted by the bodies of their preys. This is done by using heat-sensitive ion channels which are able to detect the heat of the near-infrared light. This enables the bats and snakes to superimpose thermal and visual images in the brain and thus react to their environment with greater precision. To equip retinal photoreceptors with near-infrared sensitivity, the researchers devised a three-component system. The first component contains engineered DNA that ensures that the gene coding for the heat-sensitive channel is only expressed in photoreceptors. The second component is a gold nanorod, a small particle, that efficiently absorbs near-infrared light. The third component is an antibody that ensures strong binding between the heat-sensitive channel expressed in photoreceptors and the gold nanorods that locally capture near-infrared light and locally release heat.
The researchers first tested their system in engineered mice with retinal degeneration, confirming that near-infrared light effectively excites photoreceptors and that this signal is transmitted to retinal ganglion cells, the latter representing the output of the retina towards higher visual centers in the brain. Next, they showed that stimulating the mouse eye with near-infrared light is also picked up by neurons in a brain area that is important for conscious vision, the primary visual cortex. They also designed a behavioral test in which untreated blind mice were not able to use near-infrared stimulation to learn a simple task whereas blind mice treated with the three-component system could perform the task related to near-infrared stimulus.
In collaboration with Arnold Szabo, a co-author of the paper and Assistant Professor at the Semmelweis University in Hungary, the researchers could test their new approach on human retinas that can be kept alive in culture medium for months, though blindness sets in a day or so after death by photoreceptors losing their ability to detect light. Experimental results showed that following treatment with the three-component gene therapy method, near-infrared light exposures reactivated the human retina’s visual circuitry.
“We believe that near-infrared stimulation is an important step towards providing useful vision to blind patients so that they can regain their ability to read or see faces”, says Daniel Hillier, head of the junior research group Visual Circuits and Repair at DPZ, and adds: “We want to give hope to blind people with these findings and will further intensify our research activities in this area here at DPZ within our main project, which focuses on the restoration of vision.”
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Gene therapy to restore vision
- Gene therapy candidate restores vision in some patients
Discover how a CRISPR gene editing therapy improved vision for patients with a rare eye disorder in a promising phase 1/2 trial led by Mass General Brigham.
- Clinical trial shows CRISPR gene editing has exciting potential to treat a rare form of blindness
A recent study published in The New England Journal of Medicine investigated the potential use of gene editing to correct a congenital ... indicating that the photoreceptors in these eyes could be ...
- Michigan boy receives groundbreaking gene-editing treatment to restore vision
An 11-year-old boy in Warren has made medical history. He is one of two children in the world to receive an experimental gene therapy procedure to restore vision.
- CRISPR Gene Editing Therapy Improved Vision in Trial for Inherited Blindness
For efficacy, the researchers looked at four measures: best-corrected visual acuity (BCVA); dark-adapted full-field stimulus testing (FST), visual function navigation (VNC, as measured by a maze ...
- CHOP helps restore vision in 2 children using experimental gene editing treatment
A first-of-its-kind genetic treatment at Children's Hospital of Philadelphia is restoring and improving vision.
Go deeper with Google Headlines on:
Gene therapy to restore vision
[google_news title=”” keyword=”infectious” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Incurable retinal degeneration
- Clinical trial shows CRISPR gene editing has exciting potential to treat a rare form of blindness
By Dr. Liji Thomas, MD Retinal degeneration can be inherited or acquired. In the former case, it is an incurable and progressive condition. A recent study published in The New England Journal of ...
- CRIPSR gene editing leads to improvements in vision for people with inherited blindness, clinical trial shows
Results from a clinical trial of CRISPR gene editing in 14 individuals with a form of inherited blindness show that the treatment is safe and led to measurable improvements in 11 of the participants ...
- Macular Degeneration: 11 Ways to Protect Your Eyes
It is crucial to be aware of the risk factors and symptoms associated with AMD to detect and manage the condition early.
- Save your sight: Detect macular degeneration
This is branded content for Penry Routson Optometrists. Age-related macular degeneration (AMD) is a painless and chronic disease which affects the macular region of the retina. The retina is the ...
- Researchers Stumble Upon a New Approach for Treating Degenerative Diseases
A paper out of UC Santa Barbara reveals a new connection between a particular ion transport protein and the cell’s garbage disposal, which grinds up misfolded proteins to stave off their toxic ...
Go deeper with Google Headlines on:
Incurable retinal degeneration
[google_news title=”” keyword=”incurable retinal degeneration” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]